Trevi Therapeutics, Inc. (TRVI) Q4 2024 Annual Earnings
TRVI·Reported March 18, 2025·After market close
Diluted EPS came in at $-0.11, beat the $-0.12 consensus by $0.01.
Diluted EPS
$-0.11beat by $0.01
Consensus: $-0.12
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Trevi Therapeutics, Inc.'s Q4 2024 earnings report.
Trevi Therapeutics, Inc. (TRVI) reported Q4 2024 earnings on March 18, 2025 after market close.
Trevi Therapeutics, Inc. reported diluted EPS of $-0.11 for Q4 2024.
EPS beat the consensus estimate of $-0.12 by $0.01.
You can read the 10-K periodic report (0000950170-25-041194) directly on SEC EDGAR. The filing index links above go to sec.gov.